細菌學檢測市場－全球產業規模、佔有率、趨勢、機會及預測（依細菌種類、技術、應用、組件、地區及競爭格局分類，2021-2031年）

全球細菌學檢測市場預計將從 2025 年的 277.4 億美元成長到 2031 年的 433.2 億美元，複合年成長率達到 7.71%。

本行業運用分析技術檢測、識別和測量各種基材（包括食品、自來水和臨床檢體）中的細菌污染物，以確保安全性和合規性。市場成長的主要驅動力是政府對品質標準的嚴格執行以及全球感染疾病日益普遍，這需要嚴格的監測和控制策略。此外，對預防性醫療保健的日益重視以及工業界對快速病原體檢測方法的需求不斷成長，也為該行業的發展提供了支持。

儘管市場成長前景強勁，但由於先進診斷技術的高昂營運成本和複雜的法規環境，市場仍面臨許多挑戰。中小企業往往難以承擔認證和設備維護帶來的財務負擔，這可能會延緩創新檢測方案的推出。根據歐洲醫療技術協會（MedTech Europe）預測，到2024年，體外診斷醫療設備法規（IDMDR）下的品管系統認證平均成本將達到約108,307歐元，這凸顯了製造商在將新檢測產品推向市場時面臨的巨大財務障礙。

市場促進因素

食源性疾病和食品污染事件的日益增加是推動細菌學檢測普及的主要因素。製造商面臨建立嚴格篩檢程序的壓力，以防止因污染事件導致代價高昂的產品召回，而聯邦政府為加強監管提供的資金進一步凸顯了這一需求。例如，2024年3月，美國食品藥物管理局（FDA）申請了總額為72億美元的2025會計年度計畫資金，用於加強食品和醫療產品安全。 2024年8月，美國疾病管制與預防中心（CDC）報告了一起與熟食肉品相關的大規模細胞增生李斯特菌集體爆發，這凸顯了該項資金申請的緊迫性。該事件導致57人住院，並暴露了其對公共衛生的影響，凸顯了診斷解決方案的必要性。

第二個關鍵促進因素是日益成長的水質監測需求，這主要源自於嚴格的環境法規和污水安全要求。地方政府正在加強檢測能力，以識別細菌指標並確保符合監管規定，而政府則透過為基礎設施升級提供財政支持來協助這些工作。 2024年3月，英國環境、食品和農村事務部宣布了一項優先投資計劃，旨在減少廢水溢流，並撥款1.8億英鎊用於加速改善污水管理。這筆資金將直接用於增加檢測套組和實驗室服務的採購，而這些對於環境監測至關重要。

市場挑戰

高昂的營運成本和與先進診斷技術相關的複雜監管環境，對全球細菌檢測市場的發展構成了重大障礙。製造商面臨越來越大的財務壓力，必須滿足嚴格的認證標準，這迫使他們將大量資源從研發轉移到合規和政府文件編制上。這種資金的重新分配抑制了創新，並延緩了下一代細菌檢測解決方案的上市。因此，中小企業往往難以業務永續營運，導致市場整合加劇，可供選擇的診斷工具種類減少。

這些監管負擔迫使企業重新評估其地理策略和產品上市時間，直接阻礙了市場擴張。當獲得監管核准所需的投資過高時，製造商往往會推遲進入監管嚴格的市場，或撤回那些不再具有商業性可行性的現有產品。根據2024年歐洲醫療技術展（MedTech Europe）的數據，這些限制導致選擇歐盟作為產品首發優先區域的大型體外診斷試劑製造商比例下降了40%，中小企業比例下降了12%。這一趨勢表明，合規挑戰正在積極減緩市場成長，並限制強制性安全測試機制在全球的普及。

市場趨勢

快速分子診斷技術的整合正在從根本上改變市場格局，它以更快速、更具針對性的檢測方法取代了耗時的培養方法。檢查室擴大使用多重檢測板，這種檢測板可以同時檢測單一檢體中的多種細菌和病毒，從而顯著縮短檢測結果的周轉時間，並有助於更快地做出臨床決策。這種轉變在對照護現場分子診斷系統的強勁需求中尤為明顯，這些系統使先進的檢測更貼近患者，並改善了分散式醫療環境中的管理。根據生物梅里埃公司於2024年4月發布的“2024年第一季業務回顧”，該公司分子生物學部門的銷售額同比成長18%，主要得益於非呼吸道檢測板銷售額成長19%以及該季度成功部署了400套新的SpotFire系統。

同時，隨著微生物檢查室尋求透過機器人和人工智慧最佳化工作流程效率並解決技術純熟勞工短缺問題，向高通量檢測自動化轉型正在加速。這一趨勢包括部署自動化檢體處理設備、智慧培養箱和數位成像系統，這些設備能夠標準化檢體處理流程並簡化菌落分析。透過自動化諸如接種、分類和挑取等重複性任務，實驗室可以更有效率、更可追溯地處理大量檢體，從而有效地將傳統的手動工作流程轉變為全數位化操作。根據 Copan 集團 2024 年 10 月宣佈在赫爾辛基 HUS 診斷中心安裝其首個斯堪地那維亞Colibri™ 系統的消息，該公司已在全球安裝了 90 多套自動化菌落挑取系統，其中 40 套專門安裝在歐洲，旨在提升細菌學自動化水平。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球細菌學檢測市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 細菌類型（大腸桿菌群、沙門氏菌、曲狀桿菌、李斯特菌、退伍軍人菌、其他）
  • 依技術（傳統技術與快速技術）分類
  • 依應用領域（食品飲料、水、藥品等）
  • 依組成部分（設備、檢測套組、試劑和耗材）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

6. 北美微生物檢測市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲微生物檢測市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區微生物檢測市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲微生物檢測市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

10. 南美洲微生物檢測市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球細菌學檢測市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• SGS SA
• Bureau Veritas SA
• Intertek Group plc
• Eurofins Scientific SE
• TUV SUD AG
• ALS Limited
• 3M Company
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Agilent Technologies, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Bacteriological Testing Market is projected to expand from USD 27.74 Billion in 2025 to USD 43.32 Billion by 2031, achieving a compound annual growth rate of 7.71%. This sector involves analytical techniques designed to detect, identify, and measure bacterial contaminants in diverse substrates, such as food products, water supplies, and clinical samples, to ensure safety and regulatory compliance. The market's growth is primarily fueled by the strict enforcement of government quality standards and the rising global prevalence of infectious diseases, which demand rigorous surveillance and control strategies. Additionally, the industry is supported by a growing focus on preventive healthcare and increasing industrial needs for rapid pathogen detection methods.

Despite these favorable growth prospects, the market faces significant hurdles due to the high operational costs of advanced diagnostic technologies and a complex regulatory environment. Small and medium-sized enterprises frequently struggle to manage the financial strain of certification and equipment maintenance, which can delay the adoption of innovative testing solutions. According to MedTech Europe, the average cost for quality management system certification under the In Vitro Diagnostic Regulation reached approximately €108,307 in 2024, highlighting the substantial economic barriers manufacturers encounter when introducing new testing products to the market.

Market Driver

The escalating incidence of foodborne illnesses and contamination outbreaks is a major force accelerating the adoption of bacteriological testing. Manufacturers are driven to establish rigorous screening protocols to prevent contamination incidents that result in expensive product recalls, a necessity further emphasized by federal funding designed to improve oversight. For instance, the U.S. Food and Drug Administration requested a total program funding level of $7.2 billion in March 2024 for the 2025 fiscal year to enhance the safety of food and medical products. The real-world urgency of this demand is validated by events such as the significant Listeria outbreak linked to deli meats reported by the Centers for Disease Control and Prevention in August 2024, which caused 57 hospitalizations and demonstrated the public health consequences that drive the need for diagnostic solutions.

A second critical driver is the increasing demand for water quality monitoring, propelled by strict environmental regulations and wastewater safety requirements. Municipalities are intensifying their testing regimes to identify bacterial indicators and ensure compliance, while governments support these efforts with financial commitments to upgrade infrastructure. According to a March 2024 announcement by the UK Department for Environment, Food & Rural Affairs regarding fast-tracked investments to reduce sewage spills, £180 million was allocated to accelerate wastewater management improvements. This capital directly leads to increased procurement of testing kits and laboratory services essential for environmental surveillance.

Market Challenge

The steep operational costs linked to advanced diagnostic technologies and the intricate regulatory landscape create a significant barrier to progress in the Global Bacteriological Testing Market. Manufacturers are under increasing financial pressure to meet rigorous certification standards, forcing them to divert essential resources from research and development toward compliance and administrative documentation. This reallocation of capital hampers innovation and delays the launch of next-generation bacteriological testing solutions. Consequently, smaller enterprises often find it difficult to sustain operations, resulting in market consolidation and a reduction in the variety of available diagnostic tools.

These regulatory burdens directly inhibit market expansion by compelling companies to rethink their geographic strategies and product launch timelines. When the investment required for regulatory approval becomes excessive, manufacturers often delay entry into strict markets or withdraw existing products that are no longer commercially viable. Data from MedTech Europe in 2024 indicates that the selection of the European Union as the priority region for first product launches dropped by 40% for large in vitro diagnostic manufacturers and 12% for small and medium-sized enterprises due to these constraints. This trend demonstrates how compliance challenges actively slow market growth and limit the global availability of essential safety testing mechanisms.

Market Trends

The integration of Rapid Molecular Diagnostic Technologies is fundamentally transforming the market by replacing time-consuming culture methods with faster, syndromic testing approaches. Laboratories are increasingly utilizing multiplex panels that can simultaneously detect multiple bacteria and viruses from a single sample, drastically reducing turnaround times and facilitating quicker clinical decision-making. This shift is particularly evident in the robust demand for point-of-care molecular systems that bring sophisticated testing closer to the patient, thereby improving management in decentralized settings. As reported in BioMerieux's 'First-Quarter 2024 Business Review' from April 2024, sales in the company's molecular biology division rose by 18% year-on-year, driven largely by a 19% increase in non-respiratory panels and the successful installation of 400 new SpotFire systems during the quarter.

Simultaneously, the shift toward High-Throughput Laboratory Automation is accelerating as microbiology labs seek to optimize workflow efficiency and address skilled labor shortages through robotics and artificial intelligence. This trend involves the adoption of automated specimen processors, smart incubators, and digital imaging systems that standardize sample handling and streamline colony analysis. By automating repetitive tasks such as plating, streaking, and picking, facilities can process higher volumes of samples with greater consistency and traceability, effectively converting traditional manual workflows into fully digitized operations. According to Copan Group's October 2024 announcement regarding the first Colibri(TM) installation in Scandinavia at Helsinki's HUS Diagnostic Center, the company has successfully deployed more than 90 automated colony picking systems globally, with 40 units specifically installed across Europe to enhance bacteriology automation.

Key Market Players

• SGS SA
• Bureau Veritas SA
• Intertek Group plc
• Eurofins Scientific SE
• TUV SUD AG
• ALS Limited
• 3M Company
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Agilent Technologies, Inc.

Report Scope

In this report, the Global Bacteriological Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bacteriological Testing Market, By Bacteria

• Coliform
• Salmonella
• Campylobacter
• Listeria
• Legionella and Others

Bacteriological Testing Market, By Technology

• Traditional Technology and Rapid Technology

Bacteriological Testing Market, By End Use

• Food & Beverage
• Water
• Pharmaceuticals and Others

Bacteriological Testing Market, By Component

• Instruments
• Test Kits and Reagents & Consumables

Bacteriological Testing Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bacteriological Testing Market.

Available Customizations:

Global Bacteriological Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bacteriological Testing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Bacteria (Coliform, Salmonella, Campylobacter, Listeria, Legionella and Others)
  • 5.2.2. By Technology (Traditional Technology and Rapid Technology)
  • 5.2.3. By End Use (Food & Beverage, Water, Pharmaceuticals and Others)
  • 5.2.4. By Component (Instruments, Test Kits and Reagents & Consumables)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Bacteriological Testing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Bacteria
  • 6.2.2. By Technology
  • 6.2.3. By End Use
  • 6.2.4. By Component
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Bacteriological Testing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Bacteria
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By End Use
      • 6.3.1.2.4. By Component
  • 6.3.2. Canada Bacteriological Testing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Bacteria
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By End Use
      • 6.3.2.2.4. By Component
  • 6.3.3. Mexico Bacteriological Testing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Bacteria
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By End Use
      • 6.3.3.2.4. By Component

7. Europe Bacteriological Testing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Bacteria
  • 7.2.2. By Technology
  • 7.2.3. By End Use
  • 7.2.4. By Component
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Bacteriological Testing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Bacteria
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By End Use
      • 7.3.1.2.4. By Component
  • 7.3.2. France Bacteriological Testing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Bacteria
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By End Use
      • 7.3.2.2.4. By Component
  • 7.3.3. United Kingdom Bacteriological Testing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Bacteria
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By End Use
      • 7.3.3.2.4. By Component
  • 7.3.4. Italy Bacteriological Testing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Bacteria
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By End Use
      • 7.3.4.2.4. By Component
  • 7.3.5. Spain Bacteriological Testing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Bacteria
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By End Use
      • 7.3.5.2.4. By Component

8. Asia Pacific Bacteriological Testing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Bacteria
  • 8.2.2. By Technology
  • 8.2.3. By End Use
  • 8.2.4. By Component
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Bacteriological Testing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Bacteria
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By End Use
      • 8.3.1.2.4. By Component
  • 8.3.2. India Bacteriological Testing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Bacteria
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By End Use
      • 8.3.2.2.4. By Component
  • 8.3.3. Japan Bacteriological Testing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Bacteria
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By End Use
      • 8.3.3.2.4. By Component
  • 8.3.4. South Korea Bacteriological Testing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Bacteria
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By End Use
      • 8.3.4.2.4. By Component
  • 8.3.5. Australia Bacteriological Testing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Bacteria
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By End Use
      • 8.3.5.2.4. By Component

9. Middle East & Africa Bacteriological Testing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Bacteria
  • 9.2.2. By Technology
  • 9.2.3. By End Use
  • 9.2.4. By Component
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Bacteriological Testing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Bacteria
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By End Use
      • 9.3.1.2.4. By Component
  • 9.3.2. UAE Bacteriological Testing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Bacteria
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By End Use
      • 9.3.2.2.4. By Component
  • 9.3.3. South Africa Bacteriological Testing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Bacteria
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By End Use
      • 9.3.3.2.4. By Component

10. South America Bacteriological Testing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Bacteria
  • 10.2.2. By Technology
  • 10.2.3. By End Use
  • 10.2.4. By Component
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Bacteriological Testing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Bacteria
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By End Use
      • 10.3.1.2.4. By Component
  • 10.3.2. Colombia Bacteriological Testing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Bacteria
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By End Use
      • 10.3.2.2.4. By Component
  • 10.3.3. Argentina Bacteriological Testing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Bacteria
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By End Use
      • 10.3.3.2.4. By Component

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Bacteriological Testing Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. SGS SA
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Bureau Veritas SA
• 15.3. Intertek Group plc
• 15.4. Eurofins Scientific SE
• 15.5. TUV SUD AG
• 15.6. ALS Limited
• 15.7. 3M Company
• 15.8. Thermo Fisher Scientific Inc.
• 15.9. Merck KGaA
• 15.10. Agilent Technologies, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer